The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10820 malaria professionals are enjoying the free benefits of MalariaWorld today

Plasmodium vivax malaria

NOT Open Access | Single dose tafenoquine for preventing relapse in people with plasmodium vivax malaria-an updated meta-analysis

February 14, 2020 - 16:59 -- NOT Open Access
Anjum MU, Naveed AK, Mahmood SN, Naveed OK
Travel Med Infect Dis. 2020 Feb 6:101576

Plasmodium vivax is a frequent cause of recurring malaria in endemic areas as in its latent stage it resides in liver, and is responsible for relapse.

Treatment with 8 aminoquinoline Primaquine is given for 14 days, however studies have shown dismal results with adherence to therapy. A new long acting 8 aminoquinoline, Tafenoquine was introduced that showed efficacy and safety almost similar to Primaquine in a single dose regimen, hence giving hopes for improved compliance and help in eradicating malaria.

Evaluation of the paediatric dose of chloroquine in the treatment of Plasmodium vivax malaria

July 23, 2016 - 17:13 -- Open Access
Arletta Añez, Manuel Moscoso, Cecilia Garnica and Carlos Ascaso
Malaria Journal 2016 15:371, 19 July 2016

A CQ dose of 25 mg/kg for the treatment of P. vivax malaria may be too low in children as demonstrated by the reduction in CQ concentrations in blood at day 7 of follow-up.

Medical Treatment: 

Cost-effectiveness analysis of rapid diagnostic tests for G6PD deficiency in patients with Plasmodium vivax malaria in the Brazilian Amazon

February 15, 2016 - 14:36 -- Open Access
Henry M. Peixoto, Marcelo A. M. Brito, Gustavo A. S. Romero, Wuelton M. Monteiro, Marcus V. G. de Lacerda and Maria R. F. de Oliveira
Malaria Journal 2016 15:82, 11 February 2016

The CS-G6PD strategy is cost-effective for adequately diagnosing cases and avoiding hospitalization.


A household randomized, controlled trial of the efficacy of 0.03% transfluthrin coils alone and in combination with long-lasting insecticidal nets on the incidence of Plasmodium falciparum and Plasmodium vivax malaria in Western Yunnan Province, China

June 10, 2014 - 15:20 -- Open Access
Hill N, Zhou HN, Wang P, Guo X, Carneiro I, Moore SJ
Malaria Journal 2014, 13 :208 (31 May 2014)

This is the first robust clinical evaluation of transfluthrin mosquito coils as a means to reduce malaria and the high degree of infection prevented would indicate they represent a potentially highly effective tool, which could be integrated into larger vector control programmes.


Not Open Access | A local outbreak of autochthonous Plasmodium vivax malaria in Laconia, Greece—a re-emerging infection in the southern borders of Europe?

February 12, 2013 - 17:31 -- NOT Open Access
Panos Andriopoulos, Asimoula Economopoulou, Gregoris Spanakos, George Assimakopoulos
International Journal of Infectious Diseases, Volume 17, Issue 2, February 2013, Pages e125-e128

We have presented the first large outbreak of the local transmission of autochthonous malaria cases in Greece since the 1950s. Enhanced entomological surveillance and early detection of malaria cases are crucial in order to prevent the re-emergence of malaria, not only in Greece, but in Europe as well.

Subscribe to RSS - Plasmodium vivax malaria